Article
Chemistry, Multidisciplinary
Hong Liu, Zhenfu Wen, Haolin Chen, Zeyu Yang, Zhicheng Le, Zhijia Liu, Yongming Chen, Lixin Liu
Summary: This study demonstrates the potential of modified nanoparticles to target lymph nodes and enhance immune responses for cancer therapy.
JOURNAL OF CONTROLLED RELEASE
(2022)
Review
Physiology
Lothar C. Dieterich, Carlotta Tacconi, Luca Ducoli, Michael Detmar
Summary: The lymphatic system is an important transport system in the human body, playing a crucial role in normal physiology and disease pathogenesis. The role of tumor-associated lymphatic vessels and lymphangiogenesis in lymph node metastasis has been well studied, but the mechanisms and relationship between lymphatic vessels and the dissemination of cancer cells to peripheral organs are still not fully understood. Lymphatic vessels also serve as a communication channel between tumors and the host immune system. Lymphatic endothelial cells have recently been recognized as regulators of tumor immunity and immunotherapy responsiveness.
PHYSIOLOGICAL REVIEWS
(2022)
Editorial Material
Radiology, Nuclear Medicine & Medical Imaging
Ahmad Shariftabrizi, Ravishankar Pillenahalli Maheshwarappa, Daniel Kahn, Janet Pollard
Summary: A 63-year-old man with high-risk prostate adenocarcinoma was referred for F-18-fluciclovine PET/CT to rule out metastasis in the setting of elevated PSA levels. He had a history of nodular melanoma with previous PET/CT showing metastasis, but the current PET/CT revealed false-positive uptake.
CLINICAL NUCLEAR MEDICINE
(2021)
Article
Medicine, Research & Experimental
Alexandra S. Berghe, Gheorghe Cobzac, George Dindelegan, Simona C. Senila, Corina I. Baican, Carolina M. Solomon, Liliana Rogojan, Daniel C. Leucuta, Tudor C. Drugan, Sorana D. Bolboaca
Summary: This study found that Breslow index >2 mm, presence of ulceration, and positive sentinel lymph node were risk factors for hematogenous metastases in cutaneous melanoma patients. Ulceration and male sex were also identified as risk factors for a positive sentinel lymph node. The predictors influencing the occurrence of lymphatic or hematogenous metastases may differ, with certain factors being common for both types of metastatic spread.
EXPERIMENTAL AND THERAPEUTIC MEDICINE
(2021)
Article
Biochemistry & Molecular Biology
Guendalina Lucarini, Elisa Molinelli, Caterina Licini, Giulio Rizzetto, Giulia Radi, Gaia Goteri, Monica Mattioli-Belmonte, Annamaria Offidani, Oriana Simonetti
Summary: The expression of CD9 in melanocytic nevi and cutaneous melanomas is correlated with invasiveness and metastatic potential, and it could be a valid prognostic factor for lymph node metastasis risk.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2022)
Article
Oncology
Matteo Tantari, Stefano Bogliolo, Matteo Morotti, Vincent Balaya, Florent Bouttitie, Annie Buenerd, Laurent Magaud, Fabrice Lecuru, Benedetta Guani, Patrice Mathevet
Summary: In early-stage cervical cancer, lymphatic spread does not require the proliferation of new lymphatic endothelial cells, highlighting the importance of pre-existing peritumoral lymphatic vessels in the metastatic process. None of the markers of lymphangiogenesis and proliferation evaluated were predictive of pelvic lymph node metastasis or tumor recurrence.
Article
Oncology
Tomo Sato, Yoshihisa Shimada, Takahiro Mimae, Yasuhiro Tsutani, Yoshihiro Miyata, Hiroyuki Ito, Haruhiko Nakayama, Morihito Okada, Norihiko Ikeda
Summary: The study revealed that pN and Ly statuses were independent prognostic factors in patients with clinically N0 stage I-III NSCLC, while diseases presenting with pN + with Ly + were associated with increased rates of distant and lymph node recurrence.
Review
Biochemistry & Molecular Biology
Giulio Rizzetto, Guendalina Lucarini, Edoardo De Simoni, Elisa Molinelli, Monica Mattioli-Belmonte, Annamaria Offidani, Oriana Simonetti
Summary: Cutaneous melanoma is a severe cancer with early lymph node invasiveness and increased risk of metastasis. Identifying tissue biomarkers, such as VEGF, CD9, LYVE-1, D2-40, and 31-GEP, could help predict the risk of lymph node involvement. Among these, 31-GEP shows potential for distinguishing low and high risk for positive sentinel lymph node (SLN) classes. VEGF receptor-3 and CD9 expression can be independent predictors of positive SLN, while LYVE-1 and D2-40 facilitate assessment of lymph vascular invasion as predictors of SLN status.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2023)
Article
Dermatology
J. Welzel, S. Schuh, N. De Carvalho, L. Themstrup, M. Ulrich, G. B. E. Jemec, J. Holmes, G. Pellacani
Summary: In malignant melanomas, the density of blood vessels is increased, and irregular vascular patterns are more common, especially in high stages and metastatic melanomas.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
(2021)
Article
Oncology
Fengxiang Zhang, Huaxian Chen, Dandong Luo, Zhizhong Xiong, Xianzhe Li, Shi Yin, Longyang Jin, Shi Chen, Junsheng Peng, Lei Lian
Summary: Lymphovascular invasion (LVI) and perineural invasion (PNI) are associated with poorer prognosis in gastric cancer (GC). This study aimed to investigate their prognostic value in curative resected GC patients. The incidence of LVI/PNI was significantly higher in GC patients compared to colorectal cancer patients (50.54% vs. 21.91%, p < 0.001). LVI/PNI was closely associated with disease progression and served as an independent risk factor for lymph node metastasis and overall survival in GC.
Review
Cell Biology
Noriki Fujimoto, Lothar C. Dieterich
Summary: This review discusses the role of tumor-associated lymphatic vessels in tumor progression, the mechanisms of tumor cell invasion into lymphatic vessels, and the clinical significance of lymphatic invasion in relation to local recurrence, lymph node, and distant metastasis.
Article
Cell Biology
Noelle Leary, Sarina Walser, Yuliang He, Nikola Cousin, Paulo Pereira, Alessandro Gallo, Victor Collado-Diaz, Cornelia Halin, Susana Garcia-Silva, Hector Peinado, Lothar C. Dieterich
Summary: EV-mediated communication between melanoma and lymph node endothelial cells is identified as a new pathway involved in tumor progression and immune inhibition. These extracellular vesicles are transported rapidly to lymph nodes through lymphatic vessels and interact with endothelial cells and macrophages.
JOURNAL OF EXTRACELLULAR VESICLES
(2022)
Article
Oncology
Yoon Jung Oh, Deok Hee Kim, Won Ho Han, Bang Wool Eom, Young Il Kim, Hong Man Yoon, Jong Yeul Lee, Chan Gyoo Kim, Myeong-Cherl Kook, Il Ju Choi, Young-Woo Kim, Keun Won Ryu
Summary: In early gastric cancer (EGC) patients without lymphatic invasion (LI), tumor size larger than 3 cm, submucosal invasion, and undifferentiated histologic type were significant risk factors for lymph node metastasis (LNM). The expanded criteria for endoscopic resection (ER) may be tolerable in cases without LI, even though there is a minimal risk of LNM.
Article
Pharmacology & Pharmacy
Tingting Zhu, Zhangding Wang, Tianhui Zou, Lei Xu, Shu Zhang, Yali Chen, Chen Chen, Weijie Zhang, Shouyu Wang, Qingqing Ding, Guifang Xu
Summary: Metabolic reprogramming is a hallmark of malignancies such as gastric cancer, with the rate-limiting enzyme SOAT1 identified as highly expressed in cancerous tissues and associated with advanced tumor stage and lymph node metastasis. Inhibition of SOAT1 suppresses GC cell proliferation, cholesterol ester synthesis, and lymphangiogenesis, while overexpression promotes these processes by regulating cholesterol metabolism genes. Therefore, SOAT1 may serve as a promising prognostic biomarker for guiding clinical management and treatment decisions in gastric cancer.
FRONTIERS IN PHARMACOLOGY
(2021)
Article
Dermatology
Adrienne B. Shannon, Cimarron E. Sharon, Richard J. Straker, Michael J. Carr, Andrew J. Sinnamon, Kita Bogatch, Alexandra Thaler, Nicholas Kelly, John T. Vetto, Graham Fowler, Danielle DePalo, Vernon K. Sondak, John T. Miura, Mark B. Faries, Edmund K. Bartlett, Jonathan S. Zager, Giorgos C. Karakousis
Summary: Sentinel lymph node biopsy is not routinely recommended for T1a cutaneous melanoma due to low risk of positivity. This study identified age, primary tumor location, lymphovascular invasion, and mitotic rate as factors associated with positive sentinel lymph node in T1a melanoma patients.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
(2023)
Article
Oncology
James S. Wilmott, Hussein Tawbi, Johnathan A. Engh, Nduka M. Amankulor, Brindha Shivalingam, Hiya Banerjee, Ismael A. Vergara, Hansol Lee, Peter A. Johansson, Peter M. Ferguson, Philippe Saiag, Caroline Robert, Jean -Jacques Grob, Lisa H. Butterfied, Richard A. Scolyer, John M. Kirkwood, Georgina V. Long, Michael A. Davies
Summary: The purpose of this study was to identify baseline clinical features associated with outcomes of V600 BRAF-mutant metastatic melanoma patients with melanoma brain metastases (MBM) treated with dabrafenib and trametinib. Exploratory biomarker analysis was also conducted to identify molecular and immunologic changes associated with dabrafenib in MBMs and extracranial metastases (ECM). The results showed that baseline corticosteroid treatment was associated with reduced intracranial response rate (ICRR) and progression-free survival (PFS). These findings highlight the importance of considering corticosteroid treatment in the management of MBM patients and clinical trial design.
CLINICAL CANCER RESEARCH
(2023)
Letter
Oncology
John F. Thompson, John Hyngstrom, Corrado Caraco, Jonathan S. Zager, Tiina Jahkola, Tawnya L. Bowles, Elisabetta Pennacchioli, Harald J. Hoekstra, Marc Moncrieff, Christian Ingvar, Alexander van Akkooi, Michael S. Sabel, Edward A. Levine, Michael Henderson, Reinhard Dummer, Carlo Riccardo Rossi, John M. Kane, Steven Trocha, Frances Wright, David R. Byrd, Maurice Matter, Alastair MacKenzie-Ross, Mark C. Kelley, Patrick Terheyden, Tara L. Huston, Jeffrey D. Wayne, Heather Neuman, B. Mark Smithers, Darius Desai, Jeffrey E. Gershenwald, Shlomo Schneebaum, Anja Gesierich, Lisa K. Jacobs, James M. Lewis, Cristina O'Donoghue, Armando Sardi, J. Greg McKinnon, Craig L. Slingluff, Jeffrey M. Farma, Erwin Schultz, Randall P. Scheri, Sergi Vidal-Sicart, Alessandro A. E. Testori, Richard A. Scolyer, David E. Elashoff, Alistair J. Cochran, Mark B. Faries
ANNALS OF SURGICAL ONCOLOGY
(2023)
Letter
Dermatology
Nicholas C. Allen, Elizabeth C. Paver, Nita Agar, Richard A. Scolyer, Fergal J. Moloney
AUSTRALASIAN JOURNAL OF DERMATOLOGY
(2023)
Article
Dermatology
Stephanie C. Blake, Pascale Guitera, Anne E. Cust, Claire Galea, Serigne N. Lo, Richard A. Scolyer, Bruce K. Armstrong, John F. Thompson, Scott W. Menzies, Christine Madronio, Rachael L. Morton, Graham J. Mann, Caroline G. Watts
AUSTRALASIAN JOURNAL OF DERMATOLOGY
(2023)
Letter
Dermatology
Yuan Ni, Caroline G. Watts, Richard A. Scolyer, Christine Madronio, Bruce K. Armstrong, Rachael L. Morton, Scott W. Menzies, Graham J. Mann, John F. Thompson, Serigne N. Lo, Anne E. Cust
Summary: This cross-sectional survey identified risk factors for developing a second primary melanoma. Patients with melanoma who had characteristics such as male sex, older age, high naevus count, or melanoma on the trunk or upper limbs had a substantially higher risk of subsequent melanoma and should therefore be more intensively monitored.
BRITISH JOURNAL OF DERMATOLOGY
(2023)
Article
Oncology
Alexander H. R. Varey, John F. Thompson, Julie R. Howle, Serigne N. Lo, Sydney Ch'ng, Matteo S. Carlino
Summary: Sentinel node biopsy (SNB) is considered a requirement for pathological staging of melanomas > 1 mm thick, but some argue that it may no longer be necessary for patients with T3 and T4 primary melanomas. However, the prognostic value and therapeutic benefit of knowing a patient's nodal status should not be overlooked.
EUROPEAN JOURNAL OF CANCER
(2023)
Article
Medicine, General & Internal
Nicholas C. Allen, Andrew J. Martin, Victoria A. Snaidr, Renee Eggins, Alvin H. Chong, Pablo Fernandez-Penas, Douglas Gin, Shireen Sidhu, Vanessa L. Paddon, Leith A. Banney, Adrian Lim, Edward Upjohn, Helmut Schaider, Aparna D. Ganhewa, Jennifer Nguyen, Catriona A. McKenzie, Saurabh Prakash, Catriona McLean, Alistair Lochhead, Jan Ibbetson, Andrew Dettrick, Anthony Landgren, Katherine J. Allnutt, Clare Allison, Rachael B. Davenport, Blake P. Mumford, Brittany Wong, Brendan Stagg, Alexander Tedman, Hannah Gribbin, Harrison A. Edwards, Nicholas De Rosa, Thomas Stewart, Brent J. Doolan, Yonatan Kok, Kate Simpson, Zhi M. Low, Tom Kovitwanichkanont, Richard A. Scolyer, Haryana M. Dhillon, Janette L. Vardy, Steven J. Chadban, David G. Bowen, Andrew C. Chen, Diona L. Damian
Summary: Immunosuppressed organ-transplant recipients have a higher incidence and mortality from skin cancer. Nicotinamide, a form of vitamin B3, has shown potential in preventing skin cancers. However, a placebo-controlled trial found that oral nicotinamide therapy did not reduce the number of keratinocyte cancers or actinic keratoses in immunosuppressed solid-organ transplant recipients.
NEW ENGLAND JOURNAL OF MEDICINE
(2023)
Review
Oncology
Rebecca C. Simpson, Erin R. Shanahan, Richard A. Scolyer, Georgina V. Long
Summary: Advances in the understanding of the gut microbiota's role in immune homeostasis and function have paved the way for potential improvements in cancer treatment with immune-checkpoint inhibitors. This review summarizes the current knowledge, discusses clinical methods of modulating the microbiota, and identifies future research directions. The microbiota's influence on antitumour immune responses and potential strategies to enhance treatment efficacy and safety are important areas of investigation.
NATURE REVIEWS CLINICAL ONCOLOGY
(2023)
Article
Oncology
Tuba N. Gide, Elizabeth C. Paver, Zarwa Yaseen, Nigel Maher, Nurudeen Adegoke, Alexander M. Menzies, Ines Pires da Silva, James S. Wilmott, Georgina V. Long, Richard A. Scolyer
Summary: This study evaluated the association between LAG-3 expression and clinical outcomes in metastatic melanoma patients treated with anti-LAG-3 and anti-PD-1 immunotherapy. The results showed that LAG-3 expression was related to treatment response and tumor-infiltrating lymphocytes, and patients with ≥ 1% LAG-3+ cells had longer progression-free survival.
Article
Oncology
Nurudeen A. Adegoke, Tuba N. Gide, Yizhe Mao, Camelia Quek, Ellis Patrick, Matteo S. Carlino, Serigne N. Lo, Alexander Maxwell Menzies, Ines Pires da Silva, Ismael A. Vergara, Georgina Long, Richard A. Scolyer, James S. Wilmott
Summary: This study developed a method for unsupervised classification of tumor microenvironment (TME) in metastatic melanoma and used multiplex immunohistochemistry and quantitative pathology to assess immune cell compositions for classification in relation to response to immune checkpoint inhibitors.
JOURNAL FOR IMMUNOTHERAPY OF CANCER
(2023)
Review
Oncology
Jordan W. Conway, Jorja Braden, Serigne N. Lo, Richard A. Scolyer, Matteo S. Carlino, Alexander M. Menzies, Georgina V. Long, Ines Pires da Silva
Summary: This meta-analysis found that the addition of vascular endothelial growth factor inhibitors improved survival rates in patients with liver metastases from different types of cancers.
Meeting Abstract
Oncology
Rebecca C. Simpson, Erin R. Shanahan, Marcel Batten, Ines P. Silva, Irene L. Reijers, Judith M. Versluis, Alexander M. Menzies, Maria Gonzalez, Umaimainthan Palendira, Andrew Holmes, James S. Wilmott, Christian U. Blank, Richard A. Scolyer, Georgina V. Long
Meeting Abstract
Oncology
Srikanth Manda, Adel T. Aref, Erin K. Sykes, Steven G. Williams, Jennifer M. Koh, Erin M. Humphries, Daniel Bucio-Noble, Daniela Lee-Smith, Natasha Lucas, Dylan Xavier, Alexander Menzies, Ines Da Silva, Felicity Newell, Rosemary Balleine, Peter G. Hains, Graham Mann, Phil J. Robinson, Georgina V. Long, James Wilmott, Qing Zhong, Richard A. Scolyer, Roger R. Reddel
Meeting Abstract
Oncology
Camelia Quek, Aditya Pratapa, Ines Pires da Silva, Ghamdan Al-Eryani, Aaron Mayer, Nenad Bartonicek, Kate Harvey, Oliver Braubach, Robyn P. M. Saw, Jonathan Stretch, Kerwin F. Shannon, Alexander M. Menzies, Richard A. Scolyer, Georgina V. Long, Alexander Swarbrick, James S. Wilmott